http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2744764-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ab6bd14ea86b983e8990a9c783799522
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-34
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-94
filingDate 2020-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef6f3b24f424f3e85a7d4747e87b91ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f2317e7dcd9c94a6d72436e7a200746
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_712ad2f61d76bb0fbf6411247e5ab9e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2819dce406de0ef95e27af9c0919329a
publicationDate 2021-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2744764-C1
titleOfInvention Method of minimally invasive intrauterine pleuro-amnial bypass grafting for intrauterine correction of hydrothorax in the fetus
abstract FIELD: medicine.SUBSTANCE: invention relates to the field of obstetrics and fetal surgery. Under ultrasound control and general anesthesia of the fetus, the introducer is introduced into the amniotic cavity, then into the pleural cavity of the fetus. After that, the obturator is removed. A conductor with a SDE-MED 3Fr stent, 49 mm long, is introduced into the introducer tube. The stent is squeezed out into the working area, the pigtail spiral is wrapped, which ensures its fixation in the pleural cavity. The introducer is removed. After surgical manipulation in the operating room, ultrasound monitoring of the fetal heartbeat and blood flow in the umbilical artery is performed. The next day after the operation, a repeated ultrasound examination is performed, the condition of the fetus, the position of the stent, and the amount of pleural effusion are assessed.EFFECT: method allows preserving the possibility of fetal lung development, prevents lung hypoplasia, reduces lung compression, increases the chance of newborn survival.1 cl, 1ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2786327-C1
priorityDate 2020-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018296810-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590338
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4173

Total number of triples: 21.